52 related articles for article (PubMed ID: 20651337)
1. Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells.
Shu ST; Sugimoto Y; Liu S; Chang HL; Ye W; Wang LS; Huang YW; Yan P; Lin YC
Anticancer Res; 2010 Jun; 30(6):1937-46. PubMed ID: 20651337
[TBL] [Abstract][Full Text] [Related]
2. Expression of Q227L-galphas in MCF-7 human breast cancer cells inhibits tumorigenesis.
Chen J; Bander JA; Santore TA; Chen Y; Ram PT; Smit MJ; Iyengar R
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2648-52. PubMed ID: 9482941
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells.
Li J; Yu L; Zhang H; Wu J; Yuan J; Li X; Li M
Cancer Sci; 2009 Dec; 100(12):2255-60. PubMed ID: 19764998
[TBL] [Abstract][Full Text] [Related]
4. RIN1 is a breast tumor suppressor gene.
Milstein M; Mooser CK; Hu H; Fejzo M; Slamon D; Goodglick L; Dry S; Colicelli J
Cancer Res; 2007 Dec; 67(24):11510-6. PubMed ID: 18089779
[TBL] [Abstract][Full Text] [Related]
5. Hypomethylation of DRD2 promotes breast cancer through the FLNA-ERK pathway.
Zhang S; Zhong M; Zhu H; You Q; Yuan H; Li Y
Cancer Genet; 2023 Nov; 278-279():71-78. PubMed ID: 37729778
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Tumorigenicity 5 Ameliorates Tumor Characteristics of Invasive Breast Cancer Cells
Cheng J; Li M; Tzeng CM; Gou X; Chen S
Front Oncol; 2021; 11():621500. PubMed ID: 34395234
[TBL] [Abstract][Full Text] [Related]
7. SHCBP1 Promotes the Proliferation of Breast Cancer Cells by Inhibiting CXCL2.
Yu X; Feng G; Nian R; Han S; Ke M; Wang L; Li W; Tian S; Lu H
J Cancer; 2023; 14(18):3444-3456. PubMed ID: 38021148
[TBL] [Abstract][Full Text] [Related]
8. PTPRG inhibition by DNA methylation and cooperation with RAS gene activation in childhood acute lymphoblastic leukemia.
Xiao J; Lee ST; Xiao Y; Ma X; Houseman EA; Hsu LI; Roy R; Wrensch M; de Smith AJ; Chokkalingam A; Buffler P; Wiencke JK; Wiemels JL
Int J Cancer; 2014 Sep; 135(5):1101-9. PubMed ID: 24496747
[TBL] [Abstract][Full Text] [Related]
9. PTPRG suppresses tumor growth and invasion via inhibition of Akt signaling in nasopharyngeal carcinoma.
Cheung AK; Ip JC; Chu AC; Cheng Y; Leong MM; Ko JM; Shuen WH; Lung HL; Lung ML
Oncotarget; 2015 May; 6(15):13434-47. PubMed ID: 25970784
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
Laczmanska I; Sasiadek MM
Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
[TBL] [Abstract][Full Text] [Related]
11. Tumour-specific methylation of PTPRG intron 1 locus in sporadic and Lynch syndrome colorectal cancer.
van Roon EH; de Miranda NF; van Nieuwenhuizen MP; de Meijer EJ; van Puijenbroek M; Yan PS; Huang TH; van Wezel T; Morreau H; Boer JM
Eur J Hum Genet; 2011 Mar; 19(3):307-12. PubMed ID: 21150880
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
13. Cellular and clinical impact of protein phosphatase enzyme epigenetic silencing in multiple cancer tissues.
Wiltshire E; de Moura MC; Piñeyro D; Joshi RS
Hum Genomics; 2024 Mar; 18(1):24. PubMed ID: 38475971
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes.
Ding R; Wei H; Jiang X; Wei L; Deng M; Yuan H
Front Oncol; 2022; 12():1094657. PubMed ID: 36568252
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Phosphorylation-Related Signature Participates in Cancer Development, and PTPRG Overexpression Suppresses the Cancer Progression in Clear Cell Renal Cell Carcinoma.
Huang L; Xie Y; Han W; Jiang S; Zeng L
J Immunol Res; 2022; 2022():8300187. PubMed ID: 36405010
[TBL] [Abstract][Full Text] [Related]
16. Loss of RPTPγ primes breast tissue for acid extrusion, promotes malignant transformation and results in early tumour recurrence and shortened survival.
Sloth RA; Axelsen TV; Espejo MS; Toft NJ; Voss NCS; Burton M; Thomassen M; Vahl P; Boedtkjer E
Br J Cancer; 2022 Oct; 127(7):1226-1238. PubMed ID: 35821297
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Tumor Suppressor Gene Protein Tyrosine Phosphatase Gamma in Cancer.
Boni C; Sorio C
Front Cell Dev Biol; 2021; 9():768969. PubMed ID: 35071225
[TBL] [Abstract][Full Text] [Related]
18. A Comprehensive Review of Receptor-Type Tyrosine-Protein Phosphatase Gamma (PTPRG) Role in Health and Non-Neoplastic Disease.
Boni C; Laudanna C; Sorio C
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053232
[TBL] [Abstract][Full Text] [Related]
19. miR-141 mediates recovery from acute kidney injury.
Newbury LJ; Simpson K; Khalid U; John I; de Rivera LB; Lu YA; Lopez-Anton M; Watkins WJ; Jenkins RH; Fraser DJ; Bowen T
Sci Rep; 2021 Aug; 11(1):16499. PubMed ID: 34389752
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
